Skip to content

The QWhet micro current wound stimulator, evaluation of efficacy and side effects

The QWhet micro current wound stimulator, evaluation of efficacy and side effects - The QWhet study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON55801
Enrollment
78
Registered
2020-03-20
Start date
2022-01-10
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic wounds open wounds existing for more than 3 weeks

Interventions

The intervention consists solely of adding the QWhet stimulator to the standard wound treatment.

Sponsors

Q Care Medical Services B.V.
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Patients with chronic wounds (at least 3 weeks old) - age older than 18 years - able to understand and willing to fill out questionaires

Exclusion criteria

Exclusion criteria: 1. pregnancy and lactation 2. Use of other internal electronic devices (e.g., pacemaker, internal defibrillator) 3. mental retardation 4. fever (above 38.5 degrees Celsius) 5. Active wound infection, to be assessed by the physician investigator on clinical grounds 6. under the age of 18 years 7. wounds with necrotic tissue 8. carcinoma or melanoma in the wound or adjacent skin 9. untreated osteomyelitis of the wound 10. allergy to aluminum 11. chronic wound located on the head, neck or on the thorax 12. participation in an investigational medicine or medical device study of which the primary end point has not been reached yet 13. any other condition which, at the discretion of the physician, may prevent successful completion of the study.

Design outcomes

Primary

MeasureTime frame
Percentage of patients with an ADE after 28 days of treatment with QWhet. H0: percentage of patients is larger than 5%. Ha: percentage of patients is less or equal to 5%.

Secondary

MeasureTime frame
The average percentage woundsurface area (length x width) reduction as compared to baseline after 28 days of treatment with QWhet. H0: average percentage woundsurface reduction less than 33% compared to baseline Ha: average percentage woundsurface reduction at least 33% compared to baseline

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: May 1, 2026